Citation Impact
Citing Papers
On the Estimation and Comparison of Lifetime Morbid Risks
2021
Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria – history, rationale, description, and significance
2014 Standout
Periodic limb movements in sleep exhibit a circadian rhythm that is maximal in the late evening/early night
2010
The Theory of Event Coding (TEC): A framework for perception and action planning
2001 Standout
Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"?
2000 Standout
Benzo- and Thienobenzo- Diazepines: Multi-target Drugs for CNS Disorders
2015
The association between adaptive and cognitive deficits in geriatric chronic schizophrenic patients
1997
Relationship Between Positive and Negative Symptoms of Schizophrenia and Schizotypal Symptoms in Nonpsychotic Relatives
2001
Biologic Markers and Neurochemical Correlates of Agitation and Psychosis in Dementia
1995
Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone
1998 StandoutNobel
Suicide and Suicidal Behavior
2008 Standout
Schizophrenia
2009 Standout
Neuroleptic Withdrawal in Schizophrenic Patients
1995
Updating P300: An integrative theory of P3a and P3b
2007 Standout
Conditioned Blocking in patients with paranoid, non-paranoid psychosis or obsessive compulsive disorder: Associations with symptoms, personality and monoamine metabolism
1996
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
1997
Volume of the cingulate and outcome in schizophrenia
2004
Serotonin, Aggression, and Parental Psychopathology in Children With Attention-Deficit Hyperactivity Disorder
1997
Dopamine Partial Agonists
2004
Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men
1995
MRI Study of Cavum Septi Pellucidi in Schizophrenia, Affective Disorder, and Schizotypal Personality Disorder
1998
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans
1994 Standout
Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment
2005
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia
2000 StandoutNobel
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome
2012
The role of the posterior cingulate cortex in cognition and disease
2013 Standout
Adult attachment representations, parental responsiveness, and infant attachment: A meta-analysis on the predictive validity of the Adult Attachment Interview.
1995 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
A tutorial on regularized partial correlation networks.
2018 Standout
Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter
1999
Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging
1997
Neuroimaging and personality disorders
2005
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
A review of MRI findings in schizophrenia
2001 Standout
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Characterization of impulsivity in suicide completers: Clinical, behavioral and psychosocial dimensions
2006
Social cognition, brain networks and schizophrenia
2004
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
A review of central 5-HT receptors and their function
1999 Standout
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Ventricular Enlargement in Poor-Outcome Schizophrenia
1998
Identifying a system of predominant negative symptoms: Network analysis of three randomized clinical trials
2016
Decoding mental states from brain activity in humans
2006 Standout
Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice
1999 StandoutNobel
m-Chlorophenylpiperazine Effects in Neuroleptic-Free Schizophrenic Patients
1993
The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence
1995
Serotonergic basis of antipsychotic drug effects in schizophrenia
1998
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
1997 StandoutNobel
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
The interpersonal theory of suicide.
2010 Standout
Familial Correlates of Reduced Central Serotonergic System Function in Patients With Personality Disorders
1994
The QCAE: A Questionnaire of Cognitive and Affective Empathy
2010 Standout
Do schizotypal symptoms mediate the relationship between genetic risk for schizophrenia and impaired neuropsychological performance in co-twins of schizophrenic patients?
2003
The role of 5-HT2A receptors in antipsychotic activity
1995
22q11.2 deletion syndrome
2015 Standout
A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder
2008 Standout
Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study.
2007
Haloperidol and clozapine treatment and their effect onM-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine
1993
The reactive–proactive aggression questionnaire: differential correlates of reactive and proactive aggression in adolescent boys
2006 Standout
Evidence for Functional Interactions between 5‐HT1Aand 5‐HT2AReceptors in Rat Thermoregulatory Mechanisms
1998
Le potentiel évoqué cognitif P300 (II) : variabilité interindividuelle et application clinique en psychopathologie
2000
The Brain in Schizotypal Personality Disorder: A Review of Structural MRI and CT Findings
2002
The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum
2004
The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain
1996
The P3 auditory event–related brain potential indexes major personality traits
2001
Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum
1996
Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
1997
A glutamatergic deficiency model of schizophrenia
1999 StandoutNobel
The Boundaries of Schizophrenia
1993
How antipsychotics work—From receptors to reality
2006
Frontotemporal lobar degeneration
1998 Standout
Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
2012 Standout
Risky families: Family social environments and the mental and physical health of offspring.
2002 Standout
Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders.
1998
Personality disorder and the mental representation of early social experience
1994
Schizotypal personality disorder inside and outside the schizophrenic spectrum
2002
Vulnerability to psychopathology: A biosocial model.
1999
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
The Neuropsychiatric Inventory
1997 Standout
The role of serotonin in the pathophysiology and treatment of schizophrenia
1997
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Historical Trauma in American Indian/Native Alaska Communities
2008 Standout
Hallucinogens
2004 Standout
Works of Seth Apter being referenced
Early response to haloperidol treatment in chronic schizophrenia
1993
Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia
1993
Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects
1992
Lateral ventricular enlargement in schizotypal personality disorder
1995
Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms
1990
Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: Negative symptoms
1992
Assessment of the Central Dopaminergic Index of Plasma HVA in Schizophrenia
1995
Serotonin function and treatment response to clozapine in schizophrenic patients
1993
Event-related potentials in schizotypal personality disorder
1996
Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders
1993
Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder
1991
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings
1996